Not available outside of the UK & Ireland.
Application
MRS 1523 has been used as an inhibitor of adenosine receptors in SW1990 and BxPC3 pancreatic cancer cells, LX2 human hepatic stellate cells and human coronary smooth muscle cells.
Biochem/physiol Actions
MRS 1523 is a selectiveadenosine A3 receptor antagonist in the rat.
Features and Benefits
This compound is featured on the Adenosine Receptors page of the Handbook of Receptor Classification and Signal Transduction. To browse other handbook pages, click here.
Legal Information
Sold under license from the National Institutes of Health
Packaging
5, 25 mg in glass bottle
This product has met the following criteria to qualify for the following awards: